<?xml version="1.0" encoding="UTF-8"?>
<ref id="B115-vaccines-08-00224">
 <label>115.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kam</surname>
    <given-names>Y.W.</given-names>
   </name>
   <name>
    <surname>Kien</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Roberts</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Cheung</surname>
    <given-names>Y.C.</given-names>
   </name>
   <name>
    <surname>Lamirande</surname>
    <given-names>E.W.</given-names>
   </name>
   <name>
    <surname>Vogel</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Chu</surname>
    <given-names>S.L.</given-names>
   </name>
   <name>
    <surname>Tse</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Guarner</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Zaki</surname>
    <given-names>S.R.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Antibodies against trimeric S glycoprotein protect hamsters against SARS-CoV challenge despite their capacity to mediate FcgammaRII-dependent entry into B cells in vitro</article-title>
  <source>Vaccine</source>
  <year>2007</year>
  <volume>25</volume>
  <fpage>729</fpage>
  <lpage>740</lpage>
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2006.08.011</pub-id>
  <pub-id pub-id-type="pmid">17049691</pub-id>
 </element-citation>
</ref>
